Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype
- 1 July 2014
- journal article
- case report
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 134 (1) , 178-187.e1
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- KIT GNNK splice variants: Expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cellsExperimental Hematology, 2013
- Rare, Germline Mutation of KIT With Imatinib-Resistant Multiple GI Stromal Tumors and MastocytosisJournal of Clinical Oncology, 2013
- Alternative transcription and alternative splicing in cancerPharmacology & Therapeutics, 2012
- Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activationLeukemia, 2012
- Novel, activating KIT-N822I mutation in familial cutaneous mastocytosisExperimental Hematology, 2011
- Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosisHaematologica, 2010
- Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedGenes & Development, 2010
- Generation, Isolation, and Maintenance of Human Mast Cells and Mast Cell Lines Derived from Peripheral Blood or Cord BloodCurrent Protocols in Immunology, 2010
- Mast cells and mastocytosisBlood, 2008
- Concurrent Inhibition of Kit- and FcϵRI-Mediated Signaling: Coordinated Suppression of Mast Cell ActivationThe Journal of Pharmacology and Experimental Therapeutics, 2008